Publications by authors named "Magali Lagrange"

Claim this Profile
M
Modification of adenovirus type 5 tropism for a preferential transduction of human papillomavirus-positive cancer cells.
Magali Lagrange, Charlotte Boulade-Ladame, Georges Orfanoudakis, François Deryckere

Arch Virol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracellular scFvs against the viral E6 oncoprotein provoke apoptosis in human papillomavirus-positive cancer cells.
Magali Lagrange, Charlotte Boulade-Ladame, Laurent Mailly, Etienne Weiss, Georges Orfanoudakis

Biochem Biophys Res Commun· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification using phage display of peptides promoting targeting and internalization into HPV-transformed cell lines.
Philip Robinson, Denise Stuber, François Deryckère, Philip Tedbury, Magali Lagrange

J Mol Recognit· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6.
Magali Lagrange, Sebastian Charbonnier, Georges Orfanoudakis, Philip Robinson, Katia Zanier

J Gen Virol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMAD7 is a prognostic marker in patients with colorectal cancer.
Jean-Louis Boulay, Gabriele Mild, Adam Lowy, Juergen Reuter, Magali Lagrange

Int J Cancer· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis